Cidara Therapeutics Inc buy Sievi
Start price
14.12.21
/
0%
€1.10
Target price
14.12.22
-
Performance (%)
-13.91%
End price
10.01.22
€0.95
Summary
This prediction ended on 10.01.22 with a price of €0.95. The prediction for Cidara Therapeutics Inc disappointed with a performance of -13.91%. This prediction was marked as speculative and is excluded from Sievi's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cidara Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | 0,79 % | 1,97 % | 13,39 % | 49,83 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % | 39,72 % | 89,76 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % | 49,89 % | 64,38 % |
| iShares S&P 500 | 2,50 % | 2,76 % | 30,23 % | 64,25 % |
According to Sievi what are the pros and cons of Cidara Therapeutics Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
